Neuronal Calcium Imaging, Excitability, and Plasticity Changes in the \u3cem\u3eAldh2\u3c/em\u3e\u3csup\u3e-/-\u3c/sup\u3e Mouse Model of Sporadic Alzheimer\u27s Disease by Ghoweri, Adam O. et al.
University of Kentucky 
UKnowledge 
Pharmacology and Nutritional Sciences Faculty 
Publications Pharmacology and Nutritional Sciences 
10-13-2020 
Neuronal Calcium Imaging, Excitability, and Plasticity Changes in 
the Aldh2-/- Mouse Model of Sporadic Alzheimer's Disease 
Adam O. Ghoweri 
University of Kentucky, adam.ghoweri@uky.edu 
Peter Gagolewicz 
Queen's University, Canada 
Hilaree N. Frazier 
University of Kentucky, hilaree.frazier@uky.edu 
John C. Gant 
University of Kentucky, jcgant2@uky.edu 
R. David Andrew 
Queen's University, Canada 
See next page for additional authors Follow this and additional works at: https://uknowledge.uky.edu/pharmacol_facpub 
 Part of the Medical Pharmacology Commons, and the Neurosciences Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Repository Citation 
Ghoweri, Adam O.; Gagolewicz, Peter; Frazier, Hilaree N.; Gant, John C.; Andrew, R. David; Bennett, Brian 
M.; and Thibault, Olivier, "Neuronal Calcium Imaging, Excitability, and Plasticity Changes in the Aldh2-/- 
Mouse Model of Sporadic Alzheimer's Disease" (2020). Pharmacology and Nutritional Sciences Faculty 
Publications. 116. 
https://uknowledge.uky.edu/pharmacol_facpub/116 
This Article is brought to you for free and open access by the Pharmacology and Nutritional Sciences at 
UKnowledge. It has been accepted for inclusion in Pharmacology and Nutritional Sciences Faculty Publications by 
an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
Neuronal Calcium Imaging, Excitability, and Plasticity Changes in the Aldh2-/- 
Mouse Model of Sporadic Alzheimer's Disease 
Digital Object Identifier (DOI) 
https://doi.org/10.3233/jad-200617 
Notes/Citation Information 
Published in Journal of Alzheimer's Disease, v. 77, no. 4. 
© 2020 IOS Press and the authors. All rights reserved. 
This article is published online with Open Access and distributed under the terms of the Creative 
Commons Attribution Non-Commercial License (CC BY-NC 4.0). 
Authors 
Adam O. Ghoweri, Peter Gagolewicz, Hilaree N. Frazier, John C. Gant, R. David Andrew, Brian M. Bennett, 
and Olivier Thibault 
This article is available at UKnowledge: https://uknowledge.uky.edu/pharmacol_facpub/116 




Neuronal Calcium Imaging, Excitability,
and Plasticity Changes in the Aldh2–/–
Mouse Model of Sporadic Alzheimer’s
Disease
Adam O. Ghoweria, Peter Gagolewiczb, Hilaree N. Fraziera, John C. Ganta, R. David Andrewb,
Brian M. Bennettb and Olivier Thibaulta,∗
aPharmacology and Nutritional Sciences University of Kentucky, University of Kentucky Medical Center,
Lexington, KY, USA
bBiomedical and Molecular Sciences and Centre for Neuroscience Studies, Faculty of Health Sciences,
Queen’s University, Kingston, ON, Canada
Handling Associate Editor: Sergio Ferreira
Accepted 22 July 2020
Abstract.
Background: Dysregulated signaling in neurons and astrocytes participates in pathophysiological alterations seen in the
Alzheimer’s disease brain, including increases in amyloid-, hyperphosphorylated tau, inflammation, calcium dysregulation,
and oxidative stress. These are often noted prior to the development of behavioral, cognitive, and non-cognitive deficits.
However, the extent to which these pathological changes function together or independently is unclear.
Objective: Little is known about the temporal relationship between calcium dysregulation and oxidative stress, as some
reports suggest that dysregulated calcium promotes increased formation of reactive oxygen species, while others support the
opposite. Prior work has quantified several key outcome measures associated with oxidative stress in aldehyde dehydrogenase
2 knockout (Aldh2–/–) mice, a non-transgenic model of sporadic Alzheimer’s disease.
Methods: Here, we tested the hypothesis that early oxidative stress can promote calcium dysregulation across aging by measur-
ing calcium-dependent processes using electrophysiological and imaging methods and focusing on the afterhyperpolarization
(AHP), synaptic activation, somatic calcium, and long-term potentiation in the Aldh2–/– mouse.
Results: Our results show a significant age-related decrease in the AHP along with an increase in the slow AHP amplitude in
Aldh2–/– animals. Measures of synaptic excitability were unaltered, although significant reductions in long-term potentiation
maintenance were noted in the Aldh2–/– animals compared to wild-type.
Conclusion: With so few changes in calcium and calcium-dependent processes in an animal model that shows significant
increases in HNE adducts, A, p-tau, and activated caspases across age, the current findings do not support a direct link
between neuronal calcium dysregulation and uncontrolled oxidative stress.
Keywords: Afterhyperpolarization, aging, calcium dysregulation, electrophysiology, hippocampus, HNE, intracellular, oxida-
tive stress
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INTRODUCTION
Alzheimer’s disease (AD) is a devastating condi-
tion underscored by progressive memory loss and
profound reductions in quality of life. Currently, there
are no effective disease-modifying pharmaceutical
interventions, and those that are available provide
only symptomatic relief. It is estimated that 5.4 mil-
lion Americans currently suffer from AD and this
number is projected to grow to 13.8 million indi-
viduals by the year 2050 [1]. Moreover, the cost
of patient care is cumbersome to society, healthcare
providers, and, importantly, the families involved.
Although much progress has been made in identify-
ing underlying causes and mechanisms, a treatment
for AD, much less a cure, remains elusive.
Several dysregulated intracellular signaling path-
ways that participate in the development of cognitive,
as well as non-cognitive, declines have been
described for dementias, including frontotemporal,
vascular cognitive impairment, and AD [2–5]. AD
has been characterized by several pathological mark-
ers including amyloid- (A) plaque deposition,
neurofibrillary tangles, impaired glutamatergic and
cholinergic neurotransmission, increased production
of inflammatory cytokines and oxidative stress, as
well as neuronal calcium dysregulation. A number of
transgenic animal models have been developed in an
attempt to recapitulate these pathological events, with
the goal of identifying how they manifest and promote
disease progression [6–12]. Perhaps not surprisingly
given the complexity and etiology of the disease,
few studies have provided clarity regarding the onset
of changes and the temporal associations between
these pathological events. For example, while there is
strong evidence that neuronal calcium dysregulation
can drive oxidative stress, there is also ample evi-
dence to support the contrary; that is, that oxidative
stress can dysregulate calcium homeostasis [13–20].
To address this, it is advantageous to determine the
exact temporal associations between these markers in
an attempt to highlight their role in disease progres-
sion [21–25].
Oxidative stress-induced damage is critical in the
pathogenesis of AD [26–28]. While this damage
also occurs as part of normal aging, it appears sig-
nificantly increased in the brains of AD patients
compared to age-matched elderly controls, suggest-
ing the involvement of additional oxidative factors
in AD [29–32]. Oxidative damage can be mediated
through lipid peroxidation (LPx), protein, and DNA
oxidation, decreases in mitochondrial metabolism,
and increases in advanced glycation end products
[33]. For example, 4-hydroxynonenal (HNE) is a
reactive aldehydic byproduct of oxidative stress-
induced LPx, and increases in free HNE and
HNE protein adducts have been observed in both
the brain and cerebrospinal fluid of AD patients
[31, 32, 34–37]. Studies have shown that overpro-
duction of HNE can inhibit dephosphorylation of
tau, target key mitochondrial enzymes, alter A
peptide deposition, mediate cell death, reduce synap-
tic processes/communication, and impair cognition
[38–42]. These findings squarely position HNE as
a mediator of cellular damage in oxidative stress,
and perhaps also as an initiating factor in AD
pathogenesis. Early and widespread manifestation
of oxidative stress byproducts in AD patients and
in AD animal models precede the development of
A plaques, neurofibrillary tangles, and cognitive
decline [43–49]. These temporal associations lead
to the formulation of the oxidative stress hypothe-
sis of AD [26–28]. While electrophysiological and
synaptic structure/function relationships linked to
oxidative stress can impact cellular communication
and throughput [50–53], the onset of these changes
with respect to the manifestation of the phenotype has
not been carefully characterized.
While some studies have investigated the associ-
ation between calcium dysregulation and oxidative
stress, few laboratories have directly measured neu-
ronal calcium in the presence of rising oxidative stress
loads with aging. In the current study, we used an
oxidative stress-induced model of age-related cogni-
tive impairment with a gene deletion of ALDH2, an
enzyme important for the detoxification of endoge-
nous aldehydes arising from LPx [41, 54, 55]. This
model presents with marked increases in LPx byprod-
ucts (i.e., HNE protein adducts) from as early as 3
months of age, followed by age-related increases in
A, phosphorylated tau protein (p-tau), and activated
caspases, as well as by decreases in synaptic proteins
[41]. Moreover, deficits in hippocampus-dependent
working and spatial memory tasks, together with
reductions in dorsal CA1 dendritic arborization and
spine density, are also present in this animal model
[41, 55]. The slow, age-driven progression of LPx
byproduct accumulation highlights the model’s util-
ity and uniqueness in recapitulating AD phenotypes
in the context of aging, and therefore represents a
valuable model of sporadic AD. Here, we sought
to characterize the relationship between neuronal
calcium dysregulation and oxidative stress in an
animal model that overproduces HNE adducts at
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an early age. We chose specific ages to frame the
onset of the histopathology in the model before (1.5
months), soon-after (4 months), and well-after (10
months) AD pathology manifestation. Oregon Green
Bapta-1 (OGB-1)-based neuronal calcium fluores-
cence, synaptic and post-synaptic excitability, and
long-term potentiation (LTP) changes were charac-
terized to test the hypothesis that early oxidative stress
drives calcium dysregulation. Only mild alterations
in physiological parameters were seen. This result,
combined with small changes in calcium-dependent
processes and LTP, do not support the proposal that
oxidative stress in this model leads to calcium dys-




Aldehyde dehydrogenase 2 knockout (Aldh2–/–)
mice, derived from a C57BL/6J background and
generated by a gene-targeting knockout (KO) as pre-
viously described [56], were kindly provided by
Dr. T. Kawamoto (University of Occupational and
Environmental Health, Kitakyushu, Japan). The wild-
type (WT) and Aldh2–/– cohorts used in the current
study were generated by the mating of heterozygotes
(obtained by backcrossing Aldh2–/– mice with WT
C57BL/6J mice for more than 10 generations) and
genotyping of the progeny using PCR analysis of
genomic DNA (extracted from ear punches) utiliz-
ing primers previously reported [57]. This process
allowed the generation of age- and gender-matched
WT and Aldh2–/– littermates. Experimenters were
blinded to the genotype of the animals during all data
acquisition and throughout analyses.
LTP experiments were conducted on 8-month-old
animals derived and maintained at Queen’s Uni-
versity (Kingston, Ontario, Canada). Young-adult
(1.5 months), adult (4 months), and mid-age (10
months) mice were shipped to the University of Ken-
tucky in several cohorts. Each cohort represented
animals (male and female Aldh2–/– mice and their
WT littermates) at a particular age (e.g., 4.5 weeks,
3.5 months, and 9.5 months). As only one animal
could be recorded per day, recording for each cohort
was staggered across 3–5 weeks. The average age
of each cohort was 1.5, 4, and 10 months. Male
mice were housed individually while females were
paired together. All animals were maintained on a
12 h on/12 h off light cycle and were fed Teklad
Global 18% protein rodent diet ad libitum. Routine
assessment of animal health was performed by a vet-
erinarian and animals exhibiting signs of morbidity
were excluded from the study. Treatment and han-
dling of all animals was in accordance with both
university’s Institutional Animal Care and Use Com-
mittee guidelines.
Intracellular recordings and calcium imaging
Slice preparation
Mice were anesthetized using inhalable isoflu-
rane (5%) followed by decapitation. Brains were
quickly removed and incubated in ice-cold low cal-
cium, high magnesium artificial cerebrospinal fluid
(ACSF): (in mM) 114 NaCl, 3 KCl, 10 glucose,
1.25 KH2PO4, 26 NaHCO3, 0.096 CaCl2 anhydrous,
and 7.98 MgCl2 anhydrous. Slices (350 m thick)
from the dorsal hippocampus were sectioned using
a Vibratome® 3000 (TPI; St. Louis, MO) and incu-
bated for at least 2 h at 32◦C in a humidified (95%
O2–5% CO2) interface-type chamber in normal cal-
cium ACSF: (in mM) 114 NaCl, 3 KCl, 10 glucose,
1.25 KH2PO4, 26 NaHCO3, 2 CaCl2 anhydrous, and
2 MgCl2 anhydrous. Slices were then placed on a
net in a heated recording chamber (RC-22C; Warner
Instruments, Co., Hamden, CT) at 32◦C with a
TC2Bip/HPRE2 in-line heating system (Cell Micro
Controls; Norfolk, VA) and perfused (above and
below the slice) with a continuous flow of oxygenated
normal calcium ACSF at the rate of 1.5 mL/min.
Slices were visualized under a Nikon Eclipse E600FN
microscope.
Current clamp electrophysiology
Sharp electrodes (∼80–120 M) were pulled from
1.0 mm diameter borosilicate glass capillaries (World
Precision Instruments, Inc.; Sarasota, FL) on a Sutter
Instruments P80 pipette puller (Novato, CA). Tips
were initially backfilled with a bolus of 1.25 mM
OGB-1, pH 7.4 (ThermoFisher Scientific, Catalog
number: O6806; Waltham, MA). The rest of the elec-
trode was filled with 1 M potassium methyl sulfate
(KMeSO4) in 10 mM HEPES. A bipolar stimulat-
ing electrode was placed on the Schaffer collaterals
(SC) for stimulation (0.1 ms duration) and the sharp
electrode was slowly advanced through stratum pyra-
midale of field CA1 to record primary neurons. A
stimulator (SD9K, Astro Med Inc., Grass Instru-
ments; Warwick, RI) was used for synaptic activation.
Responses were recorded through an AxoClamp-
2B amplifier (Molecular Devices LLC.; San Jose,
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CA) and digitized at ∼5–10 KHz with a Digidata®
1550B (Molecular Devices LLC.). Data were pro-
cessed through pClamp (v10.7, Molecular Devices
LLC.). While other cell types, including interneurons
and astrocytes, are present in field CA1, compact-
ness of the pyramidal layer, morphology of the cell
imaged, and spiking properties of the cell were used
to limit our recordings to only primary pyramidal
neurons.
Afterhyperpolarization (AHP)
For measures of post-synaptic excitability, cells
were held at –65 mV and action potential (AP)
threshold was set to –55 mV. Four AP were evoked
(depolarizing 150 ms current injection) to generate
the calcium-dependent AHP every 30 s for 5 min.
Three measures of the AHP were quantified: the
medium AHP (mAHP), the slow AHP (sAHP), and
the AHP duration. The mAHP was defined as the
peak hyperpolarization observed immediately after
the end of current injection. The sAHP was measured
as the change in amplitude at 800 ms post-current
injection compared to baseline. Quantification of the
AHP duration was defined as the time between peak
amplitude of the AHP and the return to baseline. We
report data on 12 neurons/8 mice (1.5 months), 11
neurons/8 mice (4 months), and 11 neurons/7 mice
(10 months) in the WT dataset, and on 17 neurons/15
mice (1.5 months), 9 neurons/7 mice (4 months),
and 13 neurons/6 mice (10 months) in the Aldh2–/–
dataset.
Input/Output (I/O) curves
For measures of synaptic excitability, cells were
held at –70 mV and stimulated every 10 s. Excitatory
post-synaptic potential (EPSP) amplitudes were mea-
sured from an increasing series of activation voltages.
Amplitudes were used to determine the threshold for
an AP and then plotted to generate I/O curves and
their slopes. We report on data from 10 neurons/7
mice (1.5 months), 10 neurons/8 mice (4 months), and
11 neurons/7 mice (10 months) in the WT dataset, and
16 neurons/15 mice (1.5 months), 8 neurons/6 mice
(4 months), and 11 neurons/6 mice (10 months) in the
Aldh2–/– dataset.
Repeated synaptic stimulation
Synaptic stimulation intensity during repeated
synaptic stimulation (RSS; 10 s, 7 Hz) was set at the
threshold for an AP. Outcome measures included
synaptic hyperpolarization and EPSP facilitation in
relation to the first EPSP (baseline) in the train.
Synaptic hyperpolarization was measured as the
mean peak hyperpolarization amplitudes following
the 6th through 9th EPSPs. The growth of the EPSP
during the train was measured early (EPSPs 6 through
9) and late (last four EPSPs) during RSS. We report
on data from 10 neurons/7 mice (1.5 months), 10 neu-
rons/8 mice (4 months), and 11 neurons/7 mice (10
months) in the WT dataset, and 15 neurons/14 mice
(1.5 months), 8 neurons/6 mice (4 months), and 11
neurons/6 mice (10 months) in the Aldh2–/– dataset.
Calcium imaging
Cells were visualized under a 40× objective using
a filter cube (Ex: 470/40 nm; Em: 525/50; Dichroic
495 nm; Chroma Technology Corp.; Bellows Falls,
VT). Imaging Workbench (INDEC BioSystems; Los
Altos, CA) was used to quantify signals. A Lambda
DG-4 (Sutter Instruments; Novato, CA) was used as
a source to activate the fluorophore with exposures in
the range of 250–800 ms, depending on the depth of
the cell imaged. OGB-1 dye was allowed to diffuse
from the tip of the recording electrode for 10–15 min
prior to initiation of calcium imaging experiments. A
photometrics camera (Teledyne Photometrics; Tuc-
son, AZ) was used to image calcium fluorescence
and kinetics. Two regions of interest (ROI) were cre-
ated: one around the cell body and another of similar
size in tissue adjacent to the imaged cell. Background
subtraction and normalization to baseline (F/F%)
were used during analysis of OGB-1 signal. For
quantification of resting fluorescence, values were
averaged before RSS and normalized to the depth
of the recorded cell. Outcome measures included rise
time, peak amplitude, decay time, and area-under-
the-curve (AUC) (F/F %*s) during RSS and were
derived using ClampFit (Molecular Devices LLC.;
San Jose, CA) and SigmaPlot (Systat Software, Inc.;
San Jose, CA). Data reported here were taken from
8 neurons/7 mice (1.5 months), 7 neurons/5 mice (4
months), and 9 neurons/6 mice (10 months) for the
WT dataset, and 8 neurons/8 mice (1.5 months), 6
neurons/5 mice (4 months), and 11 neurons/6 mice
(10 months) for the Aldh2–/– dataset.
Cell health and exclusion criteria
Only neurons that fit the following criteria were
included in this study: input resistance ≥30 M,
holding current ≤ than –350 pA, and AP peak ≥0 mV.
If the number of APs during RSS was greater than two
standard deviations (SD) from the mean, the cell was
deemed an outlier and removed from the analysis. A
summary of these values is reported in Table 1.
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Table 1
Measures of Neuronal Health and Resting Fluorescence
Genotype Age Holding Input Action Potential # of Action Resting
(months) Current (pA) Resistance (M) Amplitude (mV) Potentials Fluorescence (F/F)
WT 1.5 –83.3 ± 25.4 67.0 ± 5.4 12.8 ± 1.7 69.9 ± 0.1 68.6 ± 20.2
4 –182.5 ± 21.3 63.0 ± 3.3 7.3 ± 1.6 75.6 ± 0.4 51.0 ± 17.5
10 –152.7 ± 36.2 55.8 ± 4.7 11.4 ± 1.6 70.2 ± 1.3 79.2 ± 19.7
Aldh2–/– 1.5 –105.6 ± 21.2 65.3 ± 4.6 11.3 ± 1.4 70.0 ± 0 73.3 ± 27.9
4 –167.8 ± 29.6 55.2 ± 4.4 9.9 ± 1.5 76.0 ± 0 63.9 ± 23.6
10 –143.8 ± 20.1 68.1 ± 4.3 7.5 ± 1.1 70.5 ± 1.5 105.8 ± 24.0
Significance - ∗p < 0.01 n.s. n.s. ∗p < 0.001 n.s.
Properties of neuronal health were compared across age and genotype. Holding current and input resistance measures reflect plasma
membrane integrity and “leakiness.” Additionally, action potential amplitude during AHP data acquisition and the number of action
potentials during calcium imaging are reported. Resting fluorescence was normalized to the depth of each cell imaged. While a signif-
icant aging effect on holding current was seen from 1.5 to 4 months (p < 0.01), this was only present within the WT group. A main
effect of age on the number of action potentials triggered during imaging was seen (p < 0.001); however, this did not have an impact on
calcium (see results). Asterisks (∗) represent significant main effect of age. Numbers represent means ± SEM and “n.s.” indicates non-
significance.
LTP induction and measures
Slice preparation
Hemi-brain slices from the dorsal hippocampus
were obtained from male KO and WT mice at 8
months of age. Animals were sacrificed by decap-
itation, and the brain was rapidly extracted and
transferred into a slicing chamber containing ice-cold
ACSF ([in mM] 124 NaCl, 26.2 NaHCO3, 4.4 KCl,
1.3 MgSO4, 1 NaH2PO4, 2.5 CaCl2, 10 glucose, and
19.7 mannitol; pH 7.3–7.4) saturated with carbogen
(95% O2/5% CO2). The brain was split into two hemi-
spheres using a scalpel and sectioned into 400 m
transverse slices using a vibratome (Leica VT1200s;
Leica Microsystems, Concord, ON). Slices were then
transferred into a submerged incubation chamber
filled with ACSF, continuously bubbled with carbo-
gen, maintained at 33.5◦C, and allowed to recover for
2 h prior to recording.
Extracellular recordings
Following incubation, each slice was transferred
into a submersion-type recording chamber main-
tained at 32◦C and continuously perfused with
carbogen-saturated ACSF at a rate of 2–3 mL/min.
A concentric bipolar stimulating electrode (Rhodes
Medical instruments, Catalog Number SNE-100X;
Tujunga, CA) was placed in the SC fibers, while
a glass recording electrode (tip resistance 1–2 M)
containing ACSF was placed within the stratum
radiatum of area CA1 of the dorsal hippocam-
pus. Stimulation (0.1 ms duration) was delivered by
an electrode connected to a stimulus isolation unit
(FE180 Stimulus Isolator; AD Instruments, Colorado
Springs, CO, USA) providing a constant current
output. The field postsynaptic potentials (fPSPs) in
CA1 were recorded with glass electrodes referenced
against an Ag/AgCl pellet in the recording cham-
ber bath. The recording electrode was connected
to an Axopatch-200A amplifier (Molecular Devices
LLC.) and A/D converter (PowerLab 4/35 running v8
LabChart; AD Instruments), allowing the signal to be
filtered (low pass at 1 kHZ), digitized (10 kHz), and
stored for offline analysis. The signal was addition-
ally conditioned online using the Hum Bug (Quest
Scientific, Vancouver, BC).
I/O curves
I/O curves were established by stimulating the SC
at increasing intensities (0.5–2.0 mA in 0.1 mA incre-
ments). Data reported here were taken from 15 WT
and 10 Aldh2–/– mice (an error was made saving the
data resulting in the loss of one observation point).
Based on these curves, a stimulation intensity yield-
ing ∼50–60% of the maximal fPSP amplitude was
used for baseline and LTP induction recording.
LTP induction
Data reported here were taken from 15 WT and
11 Aldh2–/– mice. Hippocampal fPSPs (every 30 s)
were recorded until 30 min of stable baseline was
achieved (≤10% difference between successive data
points for fPSPs, averaged over 5 min epochs). Subse-
quently, high frequency stimulation (HFS) consisting
of 100 single pulses (0.1 ms at 100 Hz) per burst
(pulse intensity as determined above) was delivered
to the SC fibers. Two trains of HFS were delivered in
total, with 30 s between trains. Hippocampal fPSPs
were recorded for 60 min following the second HFS
episode.
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Fig. 1. AHP in WT and Aldh2–/– Mice Across Age. A) Representative AHP following post-synaptic depolarization with 4 action potentials.
B, C) A main effect of aging (p < 0.02) on the mAHP and sAHP was observed within each genotype. A main effect of genotype was also
present on the sAHP (p < 0.04). D) Measures of the AHP duration were unaltered across aging or genotypes. We report data on 12 neurons
(1.5 months), 11 neurons (4 months), and 11 neurons (10 months) in the WT dataset, and on 17 neurons (1.5 months), 9 neurons (4 months),
and 13 neurons (10 months) in the Aldh2–/– dataset. Asterisks (*) represent significance across aging (above left and right bars) and genotype
(top horizontal bar separated by an ampersand) at p < 0.05.
Statistical analyses
Electrophysiological and imaging data were tested
for significance on main effects of age and genotype
using two-way ANOVAs (SigmaPlot; Systat Soft-
ware, Inc.; San Jose, CA). Sex differences using
three-way ANOVAs (SigmaPlot; Systat Software,
Inc.; San Jose, CA) were also investigated, but are
not reported here (see results). Two-way repeated
measures mixed ANOVAs (GraphPad Prism 8) were
used to determine differences in the extent of LTP
in WT and Aldh2–/– mice. Greenhouse-Geisser cor-
rections were applied where appropriate. Student’s
t-tests (unpaired) were used to investigate LTP main-
tenance 40–60 min after induction. For all LTP
experiments, only one recording was obtained per
animal. A p value of <0.05 was considered to be
significant for all measures. All data are reported as
means ± standard error of the mean (SEM).
RESULTS
Previous work using Aldh2–/– mice has shown
little evidence of sex differences in this KO model
[41, 58]. Because statistical significance was quan-
titatively consistent across the variables measured
irrespective of the inclusion of sex, and because of the
low number of recorded/imaged cells in some groups,
sexes were combined for measures of calcium and
both pre- and post-synaptic excitability (Figs. 1–4).
Nevertheless, we present ANOVA results on key out-
come measures either with sex combined or separated
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Fig. 2. Extracellular Synaptic Activation. A) Example of EPSPs recorded below and at threshold of an action potential. Inset shows I/O
plot fit from EPSP amplitudes with increasing stimulation intensity. B) Synaptic excitability derived from I/O measures (slopes). Black dot
represents the time at which synaptic stimulation was initiated. We report on data from 10 neurons (1.5 months), 10 neurons (4 months), and
11 neurons (10 months) in the WT dataset, and 16 neurons (1.5 months), 8 neurons (4 months), and 11 neurons (10 months) in the Aldh2–/–
dataset. Results showed no differences across genotype or age (p > 0.05).
by sex. LTP measures were only conducted in male
WT and KO mice (Fig. 5).
Neuronal health measures
Table 1 shows outcome measures describing neu-
ronal health during electrophysiological recordings
and calcium imaging experiments. Resting fluores-
cence normalized to cell depth showed no differences
across age or genotype (p > 0.05). Input resistance
and AP amplitude were unaltered across aging and
genotype (p > 0.05). A significant main effect of
aging was observed on holding current measures
(F(2,74) = 5.288, p < 0.01; two-way ANOVA), how-
ever, post hoc analysis revealed this was only present
in the WT group (WT p = 0.025, Aldh2–/– p > 0.05).
Additionally, a significant main effect of aging was
present in the number of APs elicited during imaging
across both genotypes (F(2,48) = 17.756, p < 0.001;
two-way ANOVA). While the number of APs at 4
months was significantly higher (stimulation setting
error), this had no noticeable impact on calcium levels
(Fig. 4E, F). In fact, normalization of AUC data to the
number of action potentials triggered during activa-
tion did not alter outcomes (i.e., no significant change
in calcium with age or genotype; data not shown).
Post-synaptic excitability changes (AHP)
We characterized the calcium-dependent AHP in
WT and Aldh2–/– animals across age (Fig. 1A) and
identified a significant age-dependent reduction in the
amplitude of both the mAHP (Fig. 1B; F (2,74) =4.391,
p < 0.02; two-way ANOVA) and sAHP (Fig. 1C; F
(2,74) =5.050, p < 0.01; two-way ANOVA). A slightly
larger sAHP was also present in the Aldh2–/– group,
highlighted by a main genotype effect (F (2,74)
=4.765, p < 0.04; two-way ANOVA). Despite these
observations, the AHP duration remained unaltered
(Fig. 1D; p > 0.05). Of interest, a main effect of sex
was also observed in the mAHP (F (2,74) =4.141,
p < 0.05; three-way ANOVA) in which female mice
displayed an overall reduction in AHP amplitude
irrespective of genotype (data not shown). No sig-
nificant sex differences were present in the sAHP
or AHP duration (p > 0.05). These findings suggest
that a reduction in the AHP seems to develop with
age in this animal model irrespective of genotype.
Interestingly, our laboratory has previously shown
that in 14-month-old APP/PS1 mice, a reduction in
L-VGCC density is seen in CA1 neurons when com-
pared to WT [59]. These results differ from those seen
in aging rats and rabbits where significant increases in
calcium-mediated processes (including the AHP) are
typically observed [60–62]. Perhaps this divergence
is reflective of the particular genetic background in
the Aldh2–/– model, and highlights the nongeneral-
izable nature of the calcium hypothesis of brain aging
and dementia.
Synaptic excitability
Neuronal synaptic excitability was derived from
measures of I/O curves (Fig. 2), as well as from
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Fig. 3. Repeated Synaptic Stimulation (RSS). A) Example of RSS showing EPSP potentiation and synaptic hyperpolarization. B) Upward
arrows illustrate growth in EPSP amplitude during repeated activation (7 Hz for 10 s), while downward arrows show increased amplitude in
the synaptic hyperpolarization. Action potentials were truncated for illustration. C–E) Synaptic hyperpolarization measured during RSS and
EPSP facilitation taken during the first (early) and last (late) periods of RSS. Black dots represent the time at which synaptic stimulation
was initiated. We report on data from 10 neurons (1.5 months), 10 neurons (4 months), and 11 neurons (10 months) in the WT dataset,
and 15 neurons (1.5 months), 8 neurons (4 months), and 11 neurons (10 months) in the Aldh2–/– dataset. No differences in synaptic
hyperpolarization, early EPSP facilitation, or late EPSP facilitation were detected across age or genotype (p > 0.05).
EPSP amplitudes during RSS (Fig. 3). Given prior
work showing significant decreases in synaptophysin
(an integral membrane protein of synaptic terminals
[41]), and reports of altered dendritic morphology
in the Aldh2–/– mouse, including reduced dendritic
length and spine density [55], it is surprising that
measures of neuronal excitability (Fig. 2B) and
short-term potentiation (Fig. 3C–E) were not signif-
icantly different across age or genotype (p > 0.05).
This could reflect the resilience of this mouse
model to significant alterations in dendritic mor-
phology, highlight the presence of a successful
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Fig. 4. Changes in OGB-1 Fluorescence During 10 s RSS. A) Example of an imaged neuron loaded with OGB-1. B) Normalized fluorescence
change across time (% F/F) before, during, and after synaptic stimulation in the cellular compartment (dark line) and in the extracellular
space adjacent to the cell (gray line). C–F) Measures of calcium kinetics (rise and decay time) and somatic calcium levels (peak amplitude
and AUC). Data reported here were taken from 8 neurons (1.5 months), 7 neurons (4 months), and 9 neurons (10 months) for the WT dataset,
and 8 neurons (1.5 months), 6 neurons (4 months), and 11 neurons (10 months) for the Aldh2–/– dataset. No significant differences across
age or genotype were detected (p > 0.05).
compensatory mechanism, or provide evidence that
physiological activation under relatively low frequen-
cies is spared. Sex differences were also investigated,
but no significant differences were detected on
either I/O or RSS measures (p > 0.05; data not
shown).
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Fig. 5. LTP Outcomes. A) I/O curves for fPSP slopes (mV/ms; mean ± SEM) elicited in CA1 by single pulse stimulation of the SC in WT
and Aldh2–/– mice. The fPSP slope increased with higher stimulation intensities, but no statistical differences between the two groups were
detected (p > 0.05). B) fPSP slope (mV/ms; mean ± SEM; normalized to baseline) before and after HFS (arrow) in WT and Aldh2–/– mice.
Delivery of HFS reliably increased the fPSP slope; however, no main effect of genotype was detected (p > 0.05). Data reported here were
taken from 15 WT and 11 Aldh2–/– mice for LTP induction and 15 WT and 10 Aldh2–/– mice for I/O curves. Analysis of the maintenance
phase of LTP (the last 20 min) revealed a significant genotype effect with somewhat reduced potentiation in the Aldh2–/– animals (t = 16.84,
p < 0.0001; unpaired t-test). Asterisks (*) represent significant group fPSP slope differences at specific time points (t-test) at p < 0.05. Insets
depict typical fPSP before (smaller downward deflection) and after (larger downward deflection) HFS in WT (top) and Aldh2–/– mice
(bottom; calibration is 0.5 mV and 5 ms).
Calcium imaging
Somatic calcium kinetics before, during, and
after RSS were compared across genotype and age
(Fig. 4A, B). No significant alterations in calcium
handling were seen (Fig. 4C–F; p > 0.05). Given
that minor, if any, changes in the AHP were present,
these results are perhaps not surprising. Indeed,
larger AHPs are often associated with increases in
direct/indirect calcium measures [63–65]. Sex differ-
ences were not seen on any of the calcium measures
quantified (p > 0.05; data not shown).
Long-term synaptic plasticity changes
The slope of fPSPs recorded in dorsal CA1 of WT
and Aldh2–/– mice increased with higher stimulation
intensities (F(1.827,42.02) = 166.2, p < 0.0001; two-
way repeated measures mixed ANOVA); however,
no significant effects were noted (Fig. 5A; p > 0.05),
highlighting a lack of difference in excitability
between the two groups. LTP changes were measured
following a robust LTP induction protocol in a sub-
set of mid-age (8 months) male mice. While no main
effect of genotype was detected on measures of fPSP
slopes across the multiple phases of LTP induction
and maintenance (Fig. 5B; p > 0.05), analysis of the
data during the maintenance phase of LTP (the last
20 min) revealed a significant genotype effect with
greater fPSP slopes in WT (201 ± 5%) compared
to Aldh2–/– mice (180 ± 5%; t = 16.84, p < 0.0001;
unpaired t-test). Perhaps the use of a strong protocol
for LTP induction (2X 100 Hz) masked differences in
the initial phases of the potentiation.
DISCUSSION
Measures of calcium-dependent potentials in sin-
gle neurons are a historically-reliable method of
indirectly detecting alterations to calcium homeosta-
sis. Indeed, changes in the AHP with aging reflect
calcium channel density and function, as well as cal-
cium buffering and signaling [64, 66–69]. In this
study, we measured calcium-related processes in
Aldh2–/– and WT mice at different ages in order
to draw temporal associations between dysregulated
calcium and age-mediated increases in oxidative
stress byproducts. Based on previous literature thor-
oughly characterizing the onset of both behavioral
and cellular biomarkers, we hypothesized that in this
sporadic model of AD with uncontrolled oxidative
stress, early oxidative stress could promote calcium
dysregulation. To our surprise, however, calcium-
dependent processes were largely unaltered. Further,
while age-dependent reductions in the mAHP and
sAHP were present, alterations in synaptic processes
(both short-term and long-term), as well as calcium
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kinetics, remained relatively unchanged. However,
we did note the presence of a small, albeit signifi-
cant, reduction in LTP maintenance in the Aldh2–/–
animals compared to WT.
In this animal model, behavioral deficits are
present as early as 3.5 (novel object recognition and
Y-maze) or 6 months of age (Morris water maze)
[41]. A and p-tau accumulation is significant by 6
months, while HNE adducts and several caspases are
clearly elevated by 3 months when compared to con-
trols. Our analysis of calcium-dependent processes at
early time-points (1.5–4 months) does demonstrate a
significant reduction in the mAHP and sAHP. How-
ever, given that the mAHP and sAHP were reduced
in both the WT and the Aldh2–/– groups with age,
we cannot dissociate the effect of aging from that of
the genetic manipulation. While there has been some
evidence of genotype-mediated reductions in calcium
processes in animal models of AD [18, 59], it is sur-
prising that a significant age-dependent reduction in
the AHP was present here. Given the importance
of the genetic backgrounds in animal models and
their impact on physiological processes [70–74], it is
likely that this particular mouse model, irrespective
of the ALDH2 manipulation, presents with a reduc-
tion in the AHP across age, thus reflecting on the
non-generalizable nature of neuronal calcium dys-
regulation with age across AD models. Previous work
from different labs has reported no loss of hippocam-
pal neurons as well as similar levels of synaptic
proteins in behaviorally-impaired aged animals
compared to young counterparts [71, 72, 75]. Per-
haps the mechanism underlying the age-dependent
reduction in the AHP presented here in both the WT
and Aldh2–/– groups is dependent on the genetic
background of the animals, and may highlight an
increase in the resilience of the animal to the impact
of elevated HNE adducts. Overall, however, it does
not appear that the presence of a greater LPx burden
specifically induces calcium dysregulation. While the
electrophysiological phenotype and outcome mea-
sures were only minimally affected, several potential
mechanisms are discussed.
Firstly, in the current study, animals may not
have been exposed to sufficient cumulative oxidative
stress to alter neurophysiological properties. No elec-
trophysiological studies investigating the Aldh2–/–
mouse at more mature ages (i.e., 18 months) have
been published. Nevertheless, evidence from other
models of AD does suggest a worsening of the phe-
notype with age. Indeed, while there is a paucity of
aging studies characterizing calcium-mediated AD
phenotypes at much later ages, a significant age-
dependent increase in hippocampal L-VGCC density
and AHP amplitude has been reported in transgenic
AD mouse models at 12–18 months of age [76,
77]. Given that our work specifically addresses alter-
ations in calcium homeostasis in a sporadic model
of AD, it is not clear how these changes align with
prior literature that has commonly used transgenic
models of familial AD. Thus, it is possible that the
Aldh2–/– mouse presents with mild electrophysio-
logical alterations during early to mid-life that worsen
with more advanced age. Alternatively, the use of a
‘2-hit’ model could unmask more robust changes at
a younger age in this particular model, as previous
evidence has demonstrated the effectiveness of using
a secondary insult in models of traumatic brain injury
(TBI), Parkinson’s disease, and even schizophrenia to
detect complex or less-sensitive processes [78–81].
In fact, a previous study using this animal model
in combination with mild (TBI) recently reported
significant increases in inflammatory cytokines, as
well as sustained cognitive deficits, when compared
to sham controls [82]. In this work, administration
of anti-inflammatory agents post-TBI ameliorated
both inflammatory and cognitive impairments of the
Aldh2–/– mice.
Moreover, reports conducted in the dorsal hip-
pocampus of Aldh2–/– mice have highlighted
morphological changes in this area only, with no
alterations detected in the ventral hippocampus or
primary sensory cortex [55], suggesting that the
impact of oxidative stress may be region-selective.
In this animal model, the dissociation between
the poor behavioral phenotype and the paucity of
calcium-mediated electrophysiological changes in
the hippocampus support the notion that brain regions
other than the hippocampus can also participate in the
encoding, storing, and recalling of memory processes
[83–87]. Further, the location of the KCa AHP chan-
nels is important to consider. KCa channels, which
are critical to neuronal repolarization and the AHP,
have been mostly identified in the somatodendritic
region of pyramidal neurons [88–92]. Thus, it is pos-
sible that recordings of mostly somatic potentials
using the sharp electrode technique did not per-
mit identification of synaptic changes in dendritic
spines or finer processes negatively impacted in the
Aldh2–/– model [55]. Finally, the possibility that
the genetic manipulation may have induced a series
of compensatory cellular events including increases
in calcium buffering, mitochondrial metabolism, or
changes in the location and density of calcium or
1634 A.O. Ghoweri et al. / Neuronal Calcium Measures in Aldh2–/– Mice
potassium channels, should be considered. Future
studies investigating these potential mechanisms are
clearly needed.
With respect to the small, albeit significant, reduc-
tion in LTP in the Aldh2–/– mouse, it is possible
that the robust induction protocol used here may
have thwarted more subtle differences in synaptic
plasticity. Previous evidence has shown that age-
related deficits in LTP induction were only seen
when less robust (perithreshold) stimulation proto-
cols were used [93–97]. Future studies investigating
calcium dysregulation across different cell types and
brain regions at more advanced ages in this animal
model should be initiated to better characterize the
potential impact of oxidative stress on behavioral
outcomes. In summary, with so few changes in cal-
cium and calcium-dependent processes detected in
an animal model with significant increases in HNE
adducts, A, p-tau, and activated caspases across
age, the current findings do not support a direct link
between neuronal calcium dysregulation and uncon-
trolled oxidative stress.
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